Effects of curcumin on vascular smooth muscle cells: implications for health and disease
- PMID: 40471441
- DOI: 10.1007/s43440-025-00744-3
Effects of curcumin on vascular smooth muscle cells: implications for health and disease
Abstract
Vascular smooth muscle cells (SMCs) are pivotal in regulating vascular tone and integrity. Their dysregulation significantly contributes to the pathophysiology of cardiovascular ailments, including atherosclerosis, blood pressure, and vascular remodeling. Curcumin, a polyphenol with a natural origin in turmeric, exhibits promising therapeutic properties due to its remarkable anti-inflammatory, antioxidant, and antiproliferative characteristics. This review aims to assess the effects of curcumin on vascular SMC behavior, encompassing its impact on proliferation, migration, phenotypic switching, and extracellular matrix remodeling. The underlying molecular mechanisms are highlighted, particularly curcumin's modulation of signaling pathways such as nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and nuclear transcription factor E2-related factor-2 (Nrf2) signaling pathways, as well as its ability to decrease oxidative stress and inflammatory cytokine generation. Furthermore, we evaluate the implications of the results for vascular health and disease, emphasizing curcumin's potential to prevent or mitigate atherosclerosis, restenosis, and hypertension. Despite promising preclinical evidence, challenges related to curcumin's bioavailability and clinical translation remain.
Keywords: Cardiovascular; Curcumin; Proliferation; Signaling pathways; Smooth muscle cell.
© 2025. The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Mechanism of action and new developments in the study of curcumin in the treatment of osteoarthritis: a narrative review.Inflammopharmacology. 2025 Mar;33(3):929-940. doi: 10.1007/s10787-025-01665-6. Epub 2025 Feb 26. Inflammopharmacology. 2025. PMID: 40009345 Review.
-
The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.Cell Physiol Biochem. 2018;47(2):707-720. doi: 10.1159/000490024. Epub 2018 May 22. Cell Physiol Biochem. 2018. PMID: 29794461
-
Unraveling the Curcumin's Molecular Targets and Its Potential in Suppressing Skin Inflammation Using Network Pharmacology and In Vitro Studies.Drug Dev Res. 2025 Feb;86(1):e70058. doi: 10.1002/ddr.70058. Drug Dev Res. 2025. PMID: 39943799
-
Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2649-2664. doi: 10.1161/ATVBAHA.120.315146. Epub 2020 Sep 17. Arterioscler Thromb Vasc Biol. 2020. PMID: 32938216
-
Curcumin and acute myeloid leukemia: a golden hope, updated insights.Mol Biol Rep. 2025 Jun 11;52(1):583. doi: 10.1007/s11033-025-10692-z. Mol Biol Rep. 2025. PMID: 40498262 Review.
References
-
- Urošević M, Nikolić L, Gajić I, Nikolić V, Dinić A, Miljković V. Curcumin: biological activities and modern pharmaceutical forms. Antibiot (Basel). 2022;11(2):135. - DOI
-
- Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H. Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacol Res. 2019;147.
Publication types
LinkOut - more resources
Full Text Sources